15 Dec 2016 --- Capsugel, the US provider of capsules for the food and healthcare industries, has been sold to Swiss pharmaceutical company Lonza Group AG for $5.5bn. Lonza has bought Capsugel from private equity firm KKR, after it won out in an auction against a number of undisclosed rivals. In recent years, Capsugel has transformed its business model to become a speciality CDMO that designs, develops and manufactures a wide range of innovative dosage forms for the biopharmaceutical and consumer health and nutrition industries.
